Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
about
Bisphosphonates and risk of atrial fibrillation: a meta-analysis.Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.Data sources on drug safety evaluation: a review of recent published meta-analyses.Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone ClubAdverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.Atrial fibrillation and stroke associated with intravenous bisphosphonate therapy in older patients with cancer.Atrial fibrillation and the use of oral bisphosphonates.Use of bisphosphonates and reduced risk of colorectal cancer.Predictors of incident atrial fibrillation and influence of medications: a retrospective case-control study.Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis.Potential therapeutic competition in community-living older adults in the U.S.: use of medications that may adversely affect a coexisting condition.CTXA hip--an extension of classical DXA measurements using quantitative CT.Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study.Bisphosphonates and risk of cardiovascular events: a meta-analysis.Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials.Effects of Sigma Anti-bonding Molecule Calcium Carbonate on bone turnover and calcium balance in ovariectomized rats.The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients.Specific nephrotoxicity and cardiotoxicity of BT-CAL®, Sigma Anti-bonding Molecule Calcium Carbonate, in mice.Relationship of Bisphosphonate Therapy and Atrial Fibrillation/Flutter: Outcomes of Sleep Disorders in Older Men (MrOS Sleep) Study.Atrial fibrillation and bisphosphonate therapy.Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis.Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.Current options for the management of postmenopausal osteoporosis.Safety concerns with the long-term management of osteoporosis.Long-term risks of bisphosphonate therapy.The effects of zoledronic acid on ECG: a prospective study on patients with bone metastatic cancer.Arrhythmias during and after zoledronic acid infusion patients with bone metastasis.New insights into human farnesyl pyrophosphate synthase inhibition by second-generation bisphosphonate drugs.Bisphosphonates and esophageal cancer—a pathway through the confusion
P2860
Q33873740-1DFD23A8-0023-4D3C-AE79-5B9D164936A1Q34018048-4FF0DC67-B7E2-4621-AAC7-54EAB7E7CA3DQ34057069-6083773C-C246-47D5-9324-DB8B7B6F576DQ34099162-11030966-FE68-4828-A7E3-74FF8EAD9316Q34189582-B3AE3ED1-CDD7-449B-A835-D9DD72AA8F26Q34488705-CCC1B54B-C1C9-4D84-B704-7922C4B77DC3Q34764869-DE54985E-7814-46A4-8C1D-E1E05E3B10BDQ34877539-F63D7048-A4AE-4812-AB8F-F183A12C0D46Q35012268-BEA1DE88-1CD2-4FA7-9ADE-C34A7ECB9E96Q35050241-23299E43-A3CE-4547-BDC0-5B18A6ECBB13Q35107345-CBBEA353-E58F-48CF-B3ED-2F5F7E5FCAFDQ35122738-8EE8A487-4189-4301-9B17-0571E0C981CEQ35263110-84E9C194-635A-402A-81ED-C1F23478D0E1Q35462296-A9080D53-F2B3-4D60-A254-D71589C39263Q35644059-0629329E-87AC-412E-AD8D-98F277A61C90Q35653393-BB4B0B91-C37B-4550-9169-071426ECCD18Q36010400-77AB0058-6358-485F-BDC7-AA0D04E7FE43Q36739360-0F26940C-A6C6-4C68-81F2-A9FD5AD7897BQ37094648-F6D42FAE-73BD-4155-8B90-496BCCC9705BQ37679127-45F0AD2B-1F4B-4FC5-A23B-590C0A9FEA8EQ37856911-0CD6B8E2-74C2-4AE2-B996-4D74B2F649F4Q37862933-F5AF84E6-7189-4FC5-A308-01BCA42FF45CQ37931985-E8AC4949-656B-4A44-BF15-38C329D18717Q38101363-1DB7AA03-CEFC-4BEE-8920-A5B18CDB59E5Q38244171-4EE54358-B7DE-4FD1-8039-2BFF2B230E89Q40984313-D7C513AF-CAAF-4672-A95A-05E4083AA727Q42438761-FAFF56FA-1F6B-49AB-A436-CF2105CA3F29Q50576810-DF4C7EA9-4699-4C6F-BAAC-E7932F15B973Q56969664-259E639B-6BB7-47FD-897F-EB188B5CDF29
P2860
Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
@en
Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
@nl
type
label
Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
@en
Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
@nl
prefLabel
Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
@en
Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
@nl
P1433
P1476
Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
@en
P2093
Vinodh Jeevanantham
Yoon Kong Loke
P304
P356
10.2165/00002018-200932030-00004
P50
P577
2009-01-01T00:00:00Z
P6179
1028045029